MagBio Genomics secures 510(k), CE Mark approval

By LabPulse.com staff writers

September 12, 2022 -- MagBio Genomics announced on Monday it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as the CE Mark, for its MagXTract Collection Tube for COVID-19 testing. As a result, the firm is launching the collection tube in the U.S. and Europe.

A guanidine-free molecular transport medium, the MagXtract Collection Tube eliminates the risk of accidentally creating cyanide gas during cleaning, directly lyses cells during transport, inactivates pathogens, and maintains ambient temperature stability of RNA samples for up to eight days, thus eliminating the need for cold storage and shipping, the firm said.

The transport medium also acts as a lysis buffer, reducing costs in the nucleic acid extraction workflow, MagBio said.

MagBio specializes in developing magnetic bead-based products for molecular diagnostics and liquid biopsy genomic research.

"The MagXtract Collection Tube addresses these issues by providing cost-effective room temperature sample transportation and nucleic acid stabilization over prolonged time, providing clinical laboratories with high-quality samples for accurate molecular detection of pathogens," Hyacinth K. Ntchobo, PhD, CEO of MagBio Genomics, said in a statement.

The product will be available in the U.S. for COVID-19 testing, and in Europe for both COVID-19 and influenza testing.

N-antigen levels point to COVID severity in NIH study
Levels of SARS-CoV-2 nucleocapsid (N) antigen in the blood of patients who have been hospitalized with COVID-19 could indicate illness severity and other...
Quest Diagnostics sees decline in August COVID test demand
On the heels of nabbing a green light from the U.S. Food and Drug Administration for an Emergency Use Authorization of the first monkeypox PCR test, Quest...
CorDx obtains CE Mark for monkeypox tests
CorDx has received the CE Mark for three diagnostic tests to detect the monkeypox virus.
Nanostics secures CE Mark for ClarityDx Prostate
Nanostics has received the CE-IVD Mark for its ClarityDx Prostate test, clearing the way for its use in Europe for detecting clinically significant prostate...

Copyright © 2022 LabPulse.com

Last Updated mp 9/12/2022 11:53:00 AM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current